HGH Fragment 176-191

Unmodified lipolytic fragment related to AOD-9604. Weaker evidence than GLP-1 agonists.

What it does / how it works

Only the fat-mobilising tail of GH. It does not meaningfully raise IGF-1 the way full somatropin does. Evidence is weaker than modern GLP-1 drugs.

Class C-terminal GH fragment
Typical vial 5 mg
Reconstitution 2 mL BAC per 5 mg
Storage after mix 2–8°C, use within 28 days

Protocol

Goal Dose How often How long Route
Weeks 1-12 250-300 mcg Morning fasted, optional 2nd pin pre-stimulus 8-12 weeks SubQ
Upper 500 mcg Once daily fasted 8-12 weeks SubQ
Off None Stop 4 weeks off –

Watch: A 5 mg vial at 250 mcg twice daily lasts 10 days.

HGH Fragment 176-191 FAQ — Australia

Unmodified C-terminal fragment related to AOD-9604 (which adds an N-terminal tyrosine). Evidence quality is weaker than for GLP-1 agonists.

Recommended Supplier — HGH Fragment 176-191 Australia

Our products offer premium-grade research materials with independent testing at a leading Australian university. Every batch is strictly verified by RP-HPLC and LC-MS. For research purposes only.

Related Research — Australia

Explore similar research-grade peptides, selected to complement your research needs.

Tesamorelin + Ipamorelin

Tesamorelin target is 1-2 mg daily. Ipamorelin target....

Super Human Blend

One serving: L-Arginine 110 mg, L-Ornithine 110 mg,....

Semax + Selank

Short course. Intranasal preferred. Then 2-4 weeks off.....

Retatrutide + Cagrilintide

5+5 mg is a late stock, not a....
Select your currency
USD United States (US) dollar